Combined Synopsis/SolicitationPosted Jun 5, 2026·Responses due Jun 18, 2026

Non-Competitive RFQ for the repair of a Universal

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO

Stage
Open solicitation
NAICS
811310
Value
Not stated
Solicitation
75N98026Q00526
Set-aside
None stated
PSC
6640
Place
Not stated
Contact
Not stated
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75N98026Q00526 in this department, oldest first.

Early notice
None posted
Solicitation
  • Jun 5, 2026 · this notice
    Combined Synopsis/Solicitation
Award
  • Jul 8, 2026
    Award Notice
    NATIONWIDE POWER SOLUTIONS INC · $37K
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

Who won similar work

14 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH OLAO), same product/service code (PSC) 6640.

Single-winner award sizes (14): middle half $42K to $175K, median $69K; range $21K to $230K.

WinnerAwardsValueLast
BRUKER BIOSPIN CORP · $BRKR · $3.0B2$329KJul 30, 2026
BRUKER NANO, INC · $BRKR · $3.0B1$230KAug 14, 2026
Sony Biotechnology Inc.1$227KAug 17, 2026
NEWPORT CORP1$212KJul 8, 2026
AMUZA INC.1$115KJul 10, 2026
IRADIMED CORPORATION · $IRMD · $73.2M1$71KJun 30, 2026
PARSE BIOSCIENCES, INC.1$67KJul 8, 2026
Mirion Technologies (Capintec), Inc.1$56KJun 29, 2026
BITTIUM USA INC.1$48KAug 7, 2026
NIKON INSTRUMENTS INC1$40KSep 25, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $BRKR reported $3.0B revenue in FY2025. The median single-winner award in these 14 past awards, $69K, is under 0.1% of that. 10-K
  • $IRMD reported $73.2M revenue in FY2025. The median single-winner award in these 14 past awards, $69K, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 2 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.